A Listening Company
With the possible exception of breast cancer, biomarker testing is more established in non-small cell lung cancer (NSCLC) than in other oncology indications. If you believe that NSCLC biomarker testing is fully standardized, you would be wrong. Our survey respondents taught us that we are only at the end of the beginning of standardization of NSCLC biomarker testing.
Explore the following topics:
On a tight timeline? Call us.(949) 438-4836
Or send an email to our team:
inVibe OC (HQ)2900 Bristol St.
Building D, Suite 201Costa Mesa, CA 92626
inVibe Philly1010 N. Hancock St.Philadelphia, PA 19123
Complete the form below and we'll get back to you within 24 hours.
inVibe Labs, LLC
2900 Bristol D201
Costa Mesa, CA 92626
Tel (949) 438-4836